Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 2,785.19%1.56B | -95.32%54M | -56.85%1.15B | 165.61%2.67B | -53.81%1.01B | -14.42%2.18B | 1.19%2.55B | 44.13%2.52B | 129.61%1.75B | -56.74%760M |
Net profit before non-cash adjustment | -58.57%1.14B | 191.21%2.75B | 6.19%944M | 7.11%889M | -41.92%830M | -16.77%1.43B | 21.77%1.72B | 238.13%1.41B | 42.32%417M | -62.14%293M |
Total adjustment of non-cash items | 183.60%1.11B | -204.15%-1.33B | 39.15%1.28B | -23.20%917M | 2.75%1.19B | 9.21%1.16B | -16.94%1.06B | -11.10%1.28B | 59.23%1.44B | 33.48%905M |
-Depreciation and amortization | -11.41%1.33B | 0.54%1.5B | 10.94%1.49B | -0.59%1.34B | 3.84%1.35B | 8.14%1.3B | -12.44%1.2B | -8.27%1.38B | -1.58%1.5B | -4.69%1.52B |
-Reversal of impairment losses recognized in profit and loss | --0 | --1.91B | --0 | ---- | ---- | --4M | ---- | ---- | --313M | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 110.64%10M | 69.38%-94M |
-Disposal profit | 96.16%-177M | -4,014.29%-4.61B | -28.74%-112M | -262.50%-87M | -900.00%-24M | -62.50%3M | 107.48%8M | -117.04%-107M | 590.63%628M | -124.56%-128M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -16.03%-362M | ---312M |
-Other non-cash items | 68.75%-40M | -24.27%-128M | 69.71%-103M | -153.73%-340M | 8.84%-134M | 0.68%-147M | -1,238.46%-148M | 102.01%13M | -670.24%-647M | 84.89%-84M |
Changes in working capital | 49.34%-692M | -28.02%-1.37B | -223.21%-1.07B | 185.07%866M | -146.49%-1.02B | -75.00%-413M | -34.86%-236M | -54.87%-175M | 74.20%-113M | -243.61%-438M |
-Change in receivables | -54.52%-1.42B | -128.61%-919M | -150.25%-402M | -59.98%800M | 215.30%2B | 149.22%634M | -474.42%-1.29B | -45.40%344M | -43.70%630M | -9.83%1.12B |
-Change in inventory | 48.78%-357M | 25.77%-697M | -310.54%-939M | 728.17%446M | 92.27%-71M | -255.81%-918M | -204.45%-258M | 154.64%247M | 114.31%97M | -254.79%-678M |
-Change in payables | 115.95%1.41B | 0.46%652M | 229.28%649M | 82.65%-502M | -8,138.89%-2.89B | -97.70%36M | 423.30%1.57B | 42.26%-485M | 4.44%-840M | 36.03%-879M |
-Provision for loans, leases and other losses | 240.00%17M | 117.86%5M | -122.95%-28M | 334.62%122M | 68.48%-52M | 36.05%-165M | -545.00%-258M | ---40M | ---- | ---- |
-Changes in other current assets | 16.46%-340M | -17.29%-407M | ---347M | --0 | ---- | ---- | ---- | ---241M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 21.05%-30M | -8.57%-38M | 2.78%-35M | -20.00%-36M | 6.25%-30M | 5.88%-32M | 0.00%-34M | 29.17%-34M | 12.73%-48M | 15.38%-55M |
Interest received (cash flow from operating activities) | 3.07%168M | 19.85%163M | -12.82%136M | -8.24%156M | -6.08%170M | -3.21%181M | 11.98%187M | 0.00%167M | 10.60%167M | -18.38%151M |
Tax refund paid | 102.50%30M | -874.80%-1.2B | 76.62%-123M | -63.86%-526M | 32.28%-321M | -11.01%-474M | -48.26%-427M | -1,052.00%-288M | 89.71%-25M | -1,112.50%-243M |
Other operating cash inflow (outflow) | 107.09%263M | -57.24%127M | 191.67%297M | -97.56%-324M | 7.87%-164M | -279.80%-178M | 10,000.00%99M | -100.16%-1M | 886.59%645M | -241.38%-82M |
Operating cash flow | 322.73%1.99B | -162.54%-893M | -26.47%1.43B | 193.80%1.94B | -60.54%661M | -29.32%1.68B | 0.47%2.37B | -5.03%2.36B | 367.80%2.48B | -72.89%531M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -0.33%-1.23B | 21.17%-1.23B | 14.05%-1.55B | -311.85%-1.81B | 71.21%-439M | -23.28%-1.53B | -43.01%-1.24B | 27.37%-865M | -10.69%-1.19B | -34.84%-1.08B |
Net intangibles purchase and sale | -644.19%-320M | 32.81%-43M | 22.89%-64M | 26.55%-83M | 14.39%-113M | 44.30%-132M | -60.14%-237M | -105.56%-148M | ---72M | ---- |
Net business purchase and sale | ---- | ---- | ---- | ---689M | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | -89.91%379M | 559.12%3.76B | -44.55%570M | 1,327.78%1.03B | 148.28%72M | -17.14%29M | 537.50%35M | -119.05%-8M | -2.33%42M | -42.67%43M |
Net changes in other investments | -296.43%-111M | -450.00%-28M | 106.90%8M | -405.26%-116M | 660.00%38M | 127.78%5M | -111.54%-18M | 62.50%156M | 165.75%96M | -375.47%-146M |
Investing cash flow | -152.05%-1.28B | 336.63%2.46B | 37.65%-1.04B | -277.38%-1.67B | 72.77%-442M | -11.39%-1.62B | -68.44%-1.46B | 23.11%-865M | 4.58%-1.13B | 1.01%-1.18B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 99.56%-7M | -557.10%-1.61B | -78.67%352M | 5,256.25%1.65B | -106.39%-32M | 197.28%501M | 49.26%-515M | -74.40%-1.02B | -183.62%-582M | 363.64%696M |
Net common stock issuance | --0 | ---1M | --0 | 99.50%-1M | ---201M | --0 | ---- | ---- | ---- | ---- |
Increase or decrease of lease financing | 14.61%-76M | 12.75%-89M | 14.29%-102M | 21.19%-119M | 11.70%-151M | 12.31%-171M | 22.62%-195M | 0.40%-252M | -13.96%-253M | 2.20%-222M |
Cash dividends paid | 0.00%-314M | -50.24%-314M | 0.00%-209M | 2.79%-209M | 0.46%-215M | -33.33%-216M | -0.62%-162M | 1.23%-161M | -0.62%-163M | 0.00%-162M |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Net other fund-raising expenses | 0.00%-1M | 50.00%-1M | 0.00%-2M | 90.91%-2M | -1,000.00%-22M | 92.00%-2M | -1,150.00%-25M | 50.00%-2M | 0.00%-4M | 20.00%-4M |
Financing cash flow | 80.24%-398M | -5,264.10%-2.01B | -97.04%39M | 312.40%1.32B | -654.46%-621M | 112.49%112M | 37.27%-897M | -42.71%-1.43B | -425.32%-1B | 146.74%308M |
Net cash flow | ||||||||||
Beginning cash position | -6.85%3.37B | 14.58%3.62B | 100.57%3.16B | -15.68%1.58B | 9.30%1.87B | 0.65%1.71B | 3.16%1.7B | 34.67%1.65B | -20.79%1.22B | 7.97%1.54B |
Current changes in cash | 169.51%310M | -204.45%-446M | -73.20%427M | 496.27%1.59B | -345.12%-402M | 925.00%164M | -75.00%16M | -82.07%64M | 205.00%357M | -411.93%-340M |
Effect of exchange rate changes | -74.24%51M | 500.00%198M | 430.00%33M | -900.00%-10M | 80.00%-1M | -66.67%-5M | 72.73%-3M | -83.33%-11M | -133.33%-6M | 500.00%18M |
Cash adjustments other than cash changes | ---1M | ---- | -50.00%1M | -98.18%2M | --110M | ---- | -100.00%-2M | -101.37%-1M | 7,200.00%73M | -50.00%1M |
End cash Position | 10.67%3.73B | -6.85%3.37B | 14.58%3.62B | 100.57%3.16B | -15.68%1.58B | 9.30%1.87B | 0.65%1.71B | 3.16%1.7B | 34.67%1.65B | -20.79%1.22B |
Free cash flow | 118.88%408M | -1,037.37%-2.16B | -472.55%-190M | 103.48%51M | -8,711.76%-1.46B | -98.10%17M | -33.43%896M | 15.64%1.35B | 302.79%1.16B | -149.53%-574M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |